BioSpace News Archive

LAVA Therapeutics N.V. ( Nasdaq: LVTX ), a clinical stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T cell engagers to transform the treatment of cancer, today announced the appointments of James Noble and Jay Backstrom, M.D., M.P.H., as non-executive directors to its board of directors.

Marengo Therapeutics, Inc., a company pioneering novel therapeutics that directly target the Vβ chain of the T cell receptor (TCR) to activate the right T cell subsets to fight cancer, today announced the appointment of Svetlana Makhni as Chief Financial Officer, further bolstering Marengo’s C-suite leadership credentials.

Biogen Inc. will present new data from clinical studies aimed at assessing remaining unmet needs for people living with spinal muscular atrophy and evaluating the potential impact of SPINRAZA® in different patient populations at the SMA Research & Clinical Care Meeting hosted by Cure SMA this week in Anaheim, Calif.

Kane Biotech Inc., announces that it has further amended its credit agreement with Pivot Financial Inc. maturing August 31, 2022.

Hepion Pharmaceuticals, Inc. announced that five abstracts have been accepted for poster presentations at the European Association for the Study of the Liver International Liver Congress™ 2022 taking place June 22 – 26, 2022 in London, UK and digitally.

Extendicare Inc. announced that it has declared a cash dividend of C$0.04 per common share of the Company for the month of June 2022, which is payable on July 15, 2022 to shareholders of record at the close of business on June 30, 2022.

Image Analysis Group to Provide Imaging Strategy and Advanced Imaging Analytics in Support of MIMEDX’s Knee Osteoarthritis Clinical Trial Program.

SciSparc Ltd. announced the appointment of Prof. Ciro Leonardo Pierri as special advisor for MitoCareX Bio Ltd., SciSparc’s recently established joint venture for the discovery and development of potential drugs for cancers, infectious diseases and other life-threatening conditions.

Biostage, Inc. announced today the publication of a paper in the peer-reviewed Journal of Biomechanics, describing a study investigating the mechanical strength of regenerated esophageal tissues.

Vicente Anido Jr. , Ph.D., joins as a Strategic Advisor to advance two products to market and inform growth strategy.